A Hospital-Based Survey of Risk Factors for Diabetic Foot Ulceration in Northern Thailand

International Journal of Lower Extremity Wounds

Volumn 3, Issue 4, 2004, Pages 220-222

  Rerkasem, K ^a   Kosachunhanum, N ^a   Chongruksut, W ^a   Koiam, W ^a   Limpijarnkit, L ^a   Chimplee, K ^a   Mangklabruks, A ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

diabetes mellitus; lower extremity wounds; risk factors

Indexed keywords

EID: 84993790810     PISSN: 15347346     EISSN: None     Source Type: Journal    
DOI: 10.1177/1534734604270953     Document Type: Article

References (18)

1. Levy LA. Epidemiology and prevention of diabetic foot disease. In: Frykberg RG, editor. The high risk foot in diabetes mellitus. New York: Churchill Livingstone; 1991. p. 23-31.
2. Boyko EJ, Ahroni JH, Stensel V, et al. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care 1999; 22(7):1036-1042.
3. Boulton AJM. The pathogenesis of diabetic foot problems: an overview. Diabet Med 1996; 13: s12-S16.
4. Sumpio BE. Foot ulcers. N Engl J Med 2000; 343(11):787-793.
5. Levin ME. Pathogenesis and general management of foot lesions in the diabetic patient. In: Bowker JH, Pfeifer MA, editors. Levin and O’Neal’s The diabetic foot, 6th ed. St. Louis: Mosby; 2001. p. 219-260.
6. Murray HJ, Young MJ, Hollis S, et al. The association between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabet Med 1996; 13(11):979-982.
7. Abboud RJ, Rowley DI, Newton RW. Lower limb muscle dysfunction may contribute to foot ulceration in diabetic patients. Clin Biomech (Bristol, Avon) 2000; 15(1):37-45.
8. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329(14):977-986.
9. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352(9131):837-853.
10. Lipsky BA. Infectious problems of the foot in diabetic patients. In: Bowker JH, Pfeifer MA, editors. Levin and O’Neal’s The diabetic foot, 6th ed. St. Louis: Mosby; 2001. p. 467-480.
11. Nitiyanant W. Diabetes mellitus in Thailand. J Asean Fed Endocr Soc 1999; 17(2 suppl):18-25.
12. Benjasuratwong Y, Suthijumroom A, Nitiyanant W, et al. Diabetes study group of Thailand. Diabetes management in Thailand and the outcome. Abstract. The 9th Annual Asia-Pacific Military Medicine Conference, Bangkok, 1999.
13. Saraf SK, Shukla VK, Kaur P, et al. A clinico-epidemiological profile of non-healing wounds in an Indian hospital. J Wound Care 2000; 9(5):247-250.
14. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996; 335(14):1001-1009.
15. Shearman CP, Chulakadabba A. The value of risk factor management in patients with peripheral arterial disease. In: Earnshaw JJ, Murie JA, editors. The evidence for vascular surgery. Gloucestershire: TFM; 1999. p. 25-30.
16. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998; 317(7160):703-713.
17. Ockene IS, Miller NH. Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. Circulation 1997; 96(9):3243-3247.
18. Levy LA. Epidemiology of podiatric medical disease and disorders. In: Helfand AE, editor. Public health and podiatric medicine. Baltimore: Williams & Wilkins; 1987. p. 91.